An infringement notice with a financial penalty may be issued in response to certain breaches of the Therapeutic Goods Act 1989 (the Act). The TGA may issue an infringement notice to a business or individual as an alternative to undertaking formal court action.

Allpulse Technologies fined $50,400 for alleged advertising breaches
Status: Infringement notices issued
Alleged contraventions: Section 42DLB of the Act

Company issued $12,600 infringement notice for alleged COVID-19 advertising breach
Status: Infringement notice issued
Alleged contraventions: Section 42DLB of the Act

Doctor fined $37,800 for alleged advertising breaches including references to COVID-19
Status: Infringement notice issued
Alleged contraventions: Section 42DLB of the Act

MMS Australia fined $151,200 for alleged unlawful advertising
Status: Infringement notice issued
Alleged contraventions: Section 42DLB of the Act

Promedical Equipment fined $63,000 for alleged unlawful advertising of a COVID-19 Rapid Test kit
Status: Infringement notice issued
Alleged contraventions: Section 42DLB of the Act

WA woman fined $2,520 for alleged breaches in relation to COVID-19 test kits
Status: Infringement notice issued
Alleged contraventions: Section 41MNB of the Act

Woman fined $2,520 for alleged breaches in relation to COVID-19 test kits
Status: Infringement notice issued
Alleged contraventions: Sections 42DLB(1) of the Act

Labtest Direct issued with a $12,600 infringement notice for alleged advertising of COVID-19 test kits
Status: Infringement notice issued
Alleged contraventions: Sections 42DLB(1) of the Act

CK Surgitech issued $25,200 in infringement notices for alleged breaches in relation to COVID-19 test kits
Status: Infringement notices issued
Alleged contraventions: Sections 41FEA and 41MNC of the Act

Pete Evans' company fined for alleged COVID-19 advertising breaches
Status: Infringement notices issued
Alleged contraventions: Section 42DLB(1) of the Act

ATP Science issued infringement notices for $302,400 for alleged advertising breaches
Status: Infringement notices issued
Alleged contraventions: Sections 42DLB(1) of the Act

Oxymed Australia Pty Ltd fined $63,000 for alleged advertising breaches
Status: Infringement notices issued
Alleged contraventions: Section 42DLB(1) of the Act

Multi-level marketing company fined $37,800 for alleged advertising breaches
Status: Paid 13 February 2020
Alleged contraventions: Sections 42DMA(1) and 22(5) of the Act

Caruso's Natural Health pays $12,600 fine for false certification in relation to therapeutic good
Status: Paid 3 February 2020
Alleged contravention: Section 21B(1) of the Act

InSkin Cosmedics Group pays $37,800 in penalties for alleged supply and advertising of unapproved dermapen device
Status: Paid Friday 31 January 2020
Alleged contraventions: Sections 41MIB(1)(a)(iii) and 42DLB(1) of the Act

Mundipharma fined for misleading advertising of opioids to health professionals
Status: Paid 20 December 2019
Alleged contraventions: Section 21B(2) of the Act

Redback SARMs pays fine for advertising prescription-only substances
Status: Paid 5 September 2019
Alleged contraventions: Section 42DLB(1) of the Act

PharmaCare pays $12,600 fine for alleged advertising of cancelled therapeutic good
Status: Paid 13 August 2019
Alleged contraventions: Section 42DLB(1) of the Act

Australian traveller fined for importing unapproved products in luggage
Status: Paid 5 July 2019
Alleged contraventions: Sections 19B(4A) and 41MI(5) of the Act

Man fined for alleged importation and advertising of unapproved therapeutic goods
Status: Payment plan
Alleged contraventions: Sections 19B(4A) and 42DL(3) of the Act

Australian company pays fine for illegal medicine exports
Status: Paid 1 February 2019
Alleged contraventions: Section 19B(4A) of the Act

Company will pay over $25,000 in fines for alleged importation of unapproved therapeutic goods
Status: Paid 21 November 2018
Alleged contraventions: Sections 19B(4A) and 41MI(5) of the Act